Transforming Global Health Through Precision Biotherapeutics
SHC Therapeutics is a pre-clinical biopharmaceutical company developing next-generation bio-therapeutics using our proprietary Genomic RNA Packaging Enhancement (GRPE) platform to delivery targeted therapies.
We are uniquely positioned to develop personalized and precision bio-therapeutics across a broad range of disease areas and have a lead candidate at the pre-clinical phase utilizing our core technology.
Leveraging GRPE to create targeted treatments across a broad range of applications
Our team
With over 50 years of combined biopharmaceutical research and commercialization experience, our management team is positioned to discover, refine and develop meaningful therapeutics for the global market.
